Claudia Bucci

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Closing the Practice Gap in Secondary Prevention After Acute Coronary Syndromes: a Provincial Implementation Pathway.

Closing the Practice Gap in Secondary Prevention After Acute Coronary Syndromes: a Provincial Implementation Pathway.

Journal: The Canadian journal of cardiology

Published: August 15, 2025

Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy.

Journal: The Canadian journal of cardiology

Published: September 17, 2023

Maximizing secondary prevention for patients with ASCVD: Where does colchicine fit in cardiovascular disease prevention?

Maximizing secondary prevention for patients with ASCVD: Where does colchicine fit in cardiovascular disease prevention?

Journal: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

Published: December 21, 2022

Dual antiplatelet therapy: A new whiteboard video for patient education.

Dual antiplatelet therapy: A new whiteboard video for patient education.

Journal: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

Published: December 19, 2018

Massive Left Atrial Thrombi during Dabigatran Therapy for Nonvalvular Atrial Fibrillation.

Massive Left Atrial Thrombi during Dabigatran Therapy for Nonvalvular Atrial Fibrillation.

Journal: CASE (Philadelphia, Pa.)

Published: August 01, 2018

Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation.

Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation.

Journal: The Canadian journal of cardiology

Published: July 23, 2018

Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF).

Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF).

Journal: The American journal of cardiology

Published: January 27, 2017

Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program.

Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program.

Journal: Blood

Published: July 31, 2015

A pharmacist's guide to the 2012 update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy.

A pharmacist's guide to the 2012 update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy.

Journal: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

Published: April 29, 2015

Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit).

Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit).

Journal: The American journal of cardiology

Published: September 12, 2014

Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective.

Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective.

Journal: The Canadian journal of cardiology

Published: June 30, 2014

Does warfarin use impact hospital length of stay? A retrospective study looking at patients treated for atrial fibrillation.

Does warfarin use impact hospital length of stay? A retrospective study looking at patients treated for atrial fibrillation.

Journal: Hospital topics

Published: February 23, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026